| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Exacerbates Illness during Respiratory Syncytial Virus Infection1
* Vaccine Research Center/National Institutes of Health, Bethesda, MD 20892; and
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232
CD8+ CTL are the main effector cells responsible for resolving viral infections. However, the CTL response to respiratory syncytial virus (RSV) infection in mice facilitates viral clearance at the expense of significant immunopathology. Previous reports have shown a strong correlation between the mechanism of CTL activity and the severity of RSV-induced illness. Furthermore, experiments in perforin knockout mice revealed that antiviral cytokine production temporally correlated with RSV-induced illness. In the current study, we show that TNF-
is the dominant mediator of RSV-associated illness, and it is also important for clearance of virus-infected cells during the early stages of infection. We also demonstrate that IFN-
plays a protective role in conjunction with perforin/granzyme-mediated killing. Preliminary experiments in gld mice that express nonfunctional Fas ligand (FasL) revealed that RSV-induced illness is significantly reduced in the absence of FasL-mediated killing. Antiviral cytokine production was not elevated in the absence of FasL, suggesting a possible link between FasL and antiviral cytokine activity. This work shows that multiple phenotypic subsets of CD8+ CTLs respond to RSV infection, each with varying capacities for clearance of virus-infected cells and the induction of illness. In addition, the revelation that TNF- is the principal mediator of RSV-induced illness means that administration of TNF receptor antagonists, in combination with antiviral therapy, may be an effective method to treat RSV infections.
This article has been cited by other articles:
|
|
 |
|
  S. Munir, C. Le Nouen, C. Luongo, U. J. Buchholz, P. L. Collins, and A. Bukreyev Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells J. Virol., September 1, 2008; 82(17): 8780 - 8796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Shornick, A. G. Wells, Y. Zhang, A. C. Patel, G. Huang, K. Takami, M. Sosa, N. A. Shukla, E. Agapov, and M. J. Holtzman Airway Epithelial versus Immune Cell Stat1 Function for Innate Defense against Respiratory Viral Infection J. Immunol., March 1, 2008; 180(5): 3319 - 3328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Morrison, L. H. Thomas, M. Sharland, and J. S. Friedland RSV-infected airway epithelial cells cause biphasic up-regulation of CCR1 expression on human monocytes J. Leukoc. Biol., June 1, 2007; 81(6): 1487 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Publicover, E. Ramsburg, M. Robek, and J. K. Rose Rapid Pathogenesis Induced by a Vesicular Stomatitis Virus Matrix Protein Mutant: Viral Pathogenesis Is Linked to Induction of Tumor Necrosis Factor Alpha J. Virol., July 15, 2006; 80(14): 7028 - 7036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Oliveri, R Polosa, S T Holgate, P H Haworth, K S Babu, and H S Arshad Etanercept in chronic severe asthma * Authors' reply. Thorax, July 1, 2006; 61(7): 640 - 640. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Anghelina, L. Pewe, and S. Perlman Pathogenic Role for Virus-Specific CD4 T Cells in Mice with Coronavirus-Induced Acute Encephalitis Am. J. Pathol., July 1, 2006; 169(1): 209 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kotelkin, I. M. Belyakov, L. Yang, J. A. Berzofsky, P. L. Collins, and A. Bukreyev The NS2 Protein of Human Respiratory Syncytial Virus Suppresses the Cytotoxic T-Cell Response as a Consequence of Suppressing the Type I Interferon Response. J. Virol., June 1, 2006; 80(12): 5958 - 5967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Peebles Jr. and B. S. Graham Pathogenesis of Respiratory Syncytial Virus Infection in the Murine Model Proceedings of the ATS, August 1, 2005; 2(2): 110 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Polack, P. M. Irusta, S. J. Hoffman, M. P. Schiatti, G. A. Melendi, M. F. Delgado, F. R. Laham, B. Thumar, R. M. Hendry, J. A. Melero, et al. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin PNAS, June 21, 2005; 102(25): 8996 - 9001. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
